update on compounded tirzepatide Compounding pharmacies can resume making as FDA reconsiders shortage Compounded Tirzepatide NYC - Elite

At TrimRx, we are committed to providing you with clinically proven, personalized weight loss solutions that prioritize your safety and long-term health

In the SURPASS J-Mono trial, tirzepatide was compared to a weekly dose of 0.75 mg dulaglutide, although doses of up to 4.5 mg once weekly have been approved (and have demonstrated enhanced efficacy)

See important safety information in the footer

[DOI] [PMC free article] [PubMed] [Google Scholar] 100.Klau S., Jurinovic V., Hornung R., Herold T., Boulesteix A.L

A personalized evaluation can help determine whether a SOTA Wellness consultation is the right next step for medication selection, dosing, monitoring and long-term weight management.

The split-dosing approach (3x weekly vs once weekly) is described as maintaining more consistent hormone levels and reducing peak-related side effects